|
1
|
Liang YF: The hermaphroditism of human.
Biologic Teach. 29:51–52. 2004.
|
|
2
|
Jing H, Xinhua T and Baosheng Z: 46,XX
male syndrome genetic diagnosis and clinical analysis. Chin J
Androl. 17:68–72. 2011.(In Chinese).
|
|
3
|
Mendonca BB, Domenice S, Arnhold IJ and
Costa EM: 46, XY disorders of sex development (DSD). Clin
Endocrinol (Oxf). 70:173–187. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yanqin Y and Xiaoping L: Diagnosis and
differentiation program of sexual development disorder. J Clin
Pediatr. 25:965–970. 2007.
|
|
5
|
Xiaoyu C and Shulan Z: Research progress
of the correlation between Y-box protein 2 and gynecologic
malignancy in sex determination area. Chin J Pract Gynecol Obst.
31:1048–1051. 2015.
|
|
6
|
Xia XY, Cui YX, Lu HY, Yang B, Wang GH,
Pan LJ, Hou BS, Ge YF, Shao Y, Yao B and Huang YF: Clinical,
molecular and cytogenetic studies on 4 patients with 46,XX (SRY
positive) male syndrome. Zhonghua Nan Ke Xue. 13:1094–1097.
2007.(In Chinese). PubMed/NCBI
|
|
7
|
Martin OV, Shialis T, Lester JN, Scrimshaw
MD, Boobis AR and Voulvoulis N: Testicular dysgenesis syndrome and
the estrogen hypothesis: A quantitative meta-analysis. Environ
Health Perspect. 116:149–157. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Enhao G: Modern plastic surgery. Beijing:
People's Military Medical Press; pp. 921–933. 2002
|
|
9
|
Deng M, Zhao H, Che Z, Wang R, Qi H and
Nie W: Report of 1 case of true hermaphroditism and literature
review. Chin J Androl. 26:55–56. 2012.(In Chinese).
|
|
10
|
Zeyi C: Chinese obstetrics and gynecology.
Beijing: People's Medical Publishing House; 2014
|
|
11
|
Cui J, Dou JT, Yang GG, Gu WJ, Zang L, Jin
N, Wang XL, Yang LJ, Lu ZH, Ba JM, et al: Diagnosis and management
of ovotesticular disorders of sex development: A clinical study of
14 cases. Chin J Pract Int Med. 4:346–350. 2015.
|
|
12
|
Boujelbene N, Cosinschi A, Boujelbene N,
Khanfir K, Bhagwati S, Herrmann E, Mirimanoff RO, Ozsahin M and
Zouhair A: Pure semiuoma: A review and update. Radiat Oneol.
6:902011. View Article : Google Scholar
|
|
13
|
Tickoo SK, Hutchinson B, Bacik J, Mazumdar
M, Motzer RJ, Bajorin DF, Bosl GJ and Reuter VE: Testicular
seminoma: A clinicopathologic and immunohistechemical study of 105
cases with special reference to seminomas with atypical features.
Int J Surg Pathol. 10:23–32. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tazi H, Badraoui M, Qasmi S and Hassam B:
Metastatie pure testicular seminoma of the skin. Prog Urol.
21:76–78. 2011.(In French). View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yinghao Y: Immunohistochemical diagnosis
and differential diagnosis of testicular tumors. Chin J
Misdiagnosis. 543–546. 2006.
|
|
16
|
Liu DL, Lu YP, Shi HY, Zhu SX, Lü JW, Li
WF and Rong X: Expression of CD117 in human testicular germ cell
tumors and its diagnostic value for seminoma and nonseminoma.
Zhonghua Nan Ke Xue. 14:38–41. 2008.(In Chinese). PubMed/NCBI
|
|
17
|
Biermann K, Klingmüller D, Koch A, Pietsch
T, Schorle H, Büttner R and Zhou H: Diagnostic value of markers
M2A, OCT3/4, AP-2gamma, PLAP and c-KIT in the detection of
extragonadal seminomas. Histopathology. 49:290–297. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ying T, Yuanhua C and Anzhi W: Expression
and significance of M2A,AP-2γ,OCT3/4, PLAP and CD117 in seminoma. J
Pract Med. 27:1338–1340. 2011.
|
|
19
|
Bode PK, Barghorn A, Fritzsche FR, Riener
MO, Kristiansen G, Knuth A and Moch H: MAGEC2 is a sensitive and
novel marker for seminoma: A tissue microarray an analysis of 325
testicular germ cell tumors. Mod Pathol. 24:829–835. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Davis-Dao CA, Siegmund KD, Vandenberg DJ,
Skinner EC, Coetzee GA, Thomas DC, Pike MC and Cortessis VK:
Heteregenous effect of androgen receptor CAG tract length on
testicular germ cell tumor risk: Shorter repeats associated with
seminoma but not other histology types. Carcinogenesis.
32:1238–1243. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhenhua L, Tao X and Yunbei X: Tissue
microarray technique was used to detect the expression of CMTM2 in
human testicular tumor tissues. Chin J Male Sci. 23:3–6. 2011.(In
Chinese).
|
|
22
|
Gang L, Bo Y and Yongsheng S: Clinical
analysis of 15 cases of secondary malignant transformation of
cryptorchidism. J Beihua Univ (Nat Sci). 13:557–559. 2012.(In
Chinese).
|
|
23
|
Bigot P, Droupy S, Houlgatte A, De
Crevoisier R and Fléchon A: Stage I seminoms: Therapeutic strategy:
Surveillance, radiotherapy, chemotherapy. A case-report. Prog Urol.
21 Suppl 2:S453–S457. 2011.
|
|
24
|
Yang Z and Daguang W: Pelvic tumor
characteristics and diagnosis and treatment. Chin J Pract Surg.
31:533–535. 2011.(In Chinese).
|
|
25
|
Zhiyu W, Jian C, Lichang L, et al:
Bilateral cryptorchidism complicated with unilateral malignant
seminoma: A case report. Chin J Androl. 16:662–663. 2010.(In
Chinese).
|
|
26
|
Yu L and Xin X: Report of a case of true
glandular malignant glandular malignant transformation. Chin J
Aesthetic Med. 3:326–327. 2004.(In Chinese).
|
|
27
|
Hua X, Liu SJ, Lu L, Li CX and Yu LN:
Clinicopathological characterization of true hermaphroditism
complicated with seminoma and review of the literature. Chin J
Androl. 18:719–722. 2012.(In Chinese).
|
|
28
|
Eble JN, Sauter G, Epstein JI and
Sesterhenn IA: World Health Organization Classification of
TumoursPathology and genetics of tumours of Urinary system and male
genital organs. Lyon: IARCP Press; pp. 260–261. 2004
|
|
29
|
Qiao B and Wen Z: The diagnostic criteria
and treatment plan of cryptorchidism in children. Pract J Pediatr.
27:1847–1848. 2012.
|
